Arm A* | Arm B† | |||
---|---|---|---|---|
Auxora (n = 17) | SOC (n = 9) | Auxora (n = 3) | SOC (n = 1) | |
Age, years (mean ± SD) | 59 ± 12 | 61 ± 13 | 64 ± 14 | 36 ± NA |
Median BMI, kg/m2 (min, max) | 30 (25, 79) | 30 (23, 49) | 23 (18, 36) | 34 |
Male sex, n (%) | 7 (41) | 5 (56) | 1 (33) | 1 (100) |
Ethnicity, n (%) | ||||
White | 8 (47) | 5 (56) | 1 (33) | 0 |
Black or African American | 7 (41) | 3 (33) | 1 (33) | 1 (100) |
Asian | 0 | 1 (11) | 1 (33) | 0 |
Others/multiple | 2 (12) | 0 | 0 | 0 |
Hispanic or Latino, n (%) | 2 (12) | 1 (11) | 0 | 0 |
Diabetes, n (%) | 8 (47) | 2 (22) | 2 (67) | 0 (0) |
Hypertension, n (%) | 8 (47) | 4 (44) | 2 (67) | 0 (0) |
Median time from the onset of symptoms to randomization, days (min, max) | 9 (4, 34) | 7 (4, 11) | 11 (8, 17) | 13 |
Ferritin, ng/mL (mean ± SD) | 709 ± 553 | 772 ± 742 | 1776 ± 722 | 2151 ± NA |
CRP, mg/dL (mean ± SD) | 10 ± 7 | 12 ± 6 | 14 ± 11 | 9 ± NA |
PaO2/FiO2 (mean ± SD) | 178 ± 74 | 168 ± 78 | 106 ± 45 | 87 ± NA |
PaO2/FiO2 ≥ 201 | 7 (41) | 3 (33) | 0 | 0 |
PaO2/FiO2 101–200 | 6 (35) | 4 (44) | 2 (67) | 0 |
PaO2/FiO2 ≤ 100 | 4 (24) | 2 (22) | 1 (33) | 1 (100) |
PaO2/FiO2 101–200 ferritin ng/mL (mean ± SD) | 867 ± 712 | 910 ± 1090 | 1637 ± 963 | NA |
PaO2/FiO2 101–200 CRP mg/dL (mean ± SD) | 11 ± 5 | 13 ± 9 | 16 ± 15 | NA |